Summary

Report Scope
This report provides an overview of the global organoids and spheroids market by analyzing its trends. The market is defined as the revenue generated by companies that derive their revenue from the sale of products and technologies used to develop organoids and spheroids, as well as companies that develop, grow, and commercialize organoid and spheroid models.
The report includes global revenue ($ millions), with 2025 as the base year, estimates for 2026, and forecasts through 2031. The market is segmented by product type, application, end user, and region. Based on product type, the market is categorized into organoid and spheroid. Based on applications, the market is segregated into drug discovery and personalized medicine, developmental biology, disease pathology studies, drug toxicity and efficacy testing, and regenerative medicine. The regions covered in this study are North America, Europe, Asia-Pacific, South America, and the Middle East and Africa, with a focus on major countries in each region.
The report focuses on the significant trends and challenges that affect the market and vendor landscape. The market analysis covers the adoption of organoids and spheroids by various end users, including pharmaceutical and biotechnology companies, academic and research institutes, contract research organizations, hospitals and diagnostic centers, and other end users.
The report concludes with an analysis of the competitive landscape, which provides rankings and market shares for key businesses in the global organoids and spheroids market.
Report Includes
- Overview of the global organoids and spheroids market, highlighting the growing use of advanced 3D cell culture models in biomedical research, drug development, and precision medicine
- Revenue analysis for the base year 2025, together with market estimates for 2026 and forecasts through 2031 across major regional markets
- Breakdown of the market by type, application, end user, and region
- Discussion of the major growth drivers, restraints, and emerging opportunities influencing the adoption of organoid and spheroid technologies worldwide
- Insights into technological advancements, including innovations in spheroid technologies, CRISPR integration, bioprinting, and patent activity supporting next-generation research models
- Regional assessment of North America, Europe, Asia-Pacific, South America, and the Middle East & Africa, with country-level analysis of leading markets
- Competitive landscape review featuring market share analysis, company rankings, and strategic initiatives undertaken by established companies and emerging innovators
- Profiles of leading market companies, highlighting their business overview, product offerings, and recent developments

ページTOPに戻る

Table of Contents

Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Market Dynamics and Growth Factors
Emerging Technologies
Segmental Analysis
Regional Analysis
Conclusion
Chapter 2 Market Overview
Market Definition
Organoids and Spheroids Overview
Organoids Versus Spheroids
Future Directions in Organoids and Spheroids Market
Porter's Five Forces Analysis
Threat of New Entrants (Moderate)
Bargaining Power of Suppliers (Moderate to High)
Bargaining Power of Buyers (Moderate)
Threat of Substitutes (Moderate)
Level of Competitiveness (High)
Macroeconomic Factors Analysis
Demographic Trends and Disease Burden
Government Funding and Research Investments
Healthcare Expenditure and Economic Growth
Regulatory and Ethical Evolution
Impact of U.S.-Iran Conflict on the Organoids and Spheroids Market
Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
Increasing Adoption of 3D Cell Culture Models Over Conventional 2D Cell Cultures
Shift Toward Human-Relevant Alternatives to Animal Testing in Preclinical Research
Rising Adoption of Organoids and Spheroids in Oncology Drug Discovery
Market Restraints
High Costs of Advanced 3D Cell Culture Systems
Lack of Standardized Protocols and Quality Control
Reproducibility Challenges
Market Opportunities
Expansion of Personalized Medicine and Precision Oncology
Growing Applications of Organoids in Regenerative Medicine and Tissue Engineering
Emergence of Automated High-Throughput Organoid Platforms
Chapter 4 Regulatory Landscape
Overview
Regulations and Standards by Country or Region
Chapter 5 Emerging Technologies and Patent Analysis
Overview
Emerging Technologies
Advances in 3D Spheroid Engineering Technologies
Integration of CRISPR and Genome Editing with Organoid Models
Emergence of 3D Bioprinting for Complex Organoid Assembly
Patent Analysis
By Year
By Jurisdiction
Chapter 6 Market Segmentation Analysis
Segmentation Breakdown
Market Analysis by Product Type
Key Takeaways
Organoids
Spheroids
Market Analysis by Application
Key Takeaways
Drug Discovery and Personalized Medicine
Developmental Biology
Disease Pathology Studies
Drug Toxicity and Efficacy Testing
Regenerative Medicine
Market Analysis by End User
Key Takeaways
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Contract Research Organizations
Hospitals and Diagnostic Centers
Other End Users
Geographic Breakdown
Market Analysis by Region
Key Takeaways
North America
Europe
Asia-Pacific
South America
Middle East and Africa
Chapter 7 Competitive Intelligence
Key Takeaways
Competitive Landscape
Strategic Analysis
Chapter 8 Appendix
Research Methodology
References
Abbreviations
Company Profiles
BIO-TECHNE
CORNING INC.
GREINER BIO-ONE INTERNATIONAL GMBH
INSPHERO
LONZA
MERCK KGAA
MOLECULAR DEVICES LLC.
REVVITY
STEMCELL TECHNOLOGIES
THERMO FISHER SCIENTIFIC INC.
A Few Emerging Startups/Market Disruptors

ページTOPに戻る

List of Tables/Graphs

List of Tables
Summary Table : Global Market for Organoids and Spheroids, by Region, Through 2031
Table 1 : Difference between Organoids and Spheroids
Table 2 : Porter’s Five Forces: Rating Scale
Table 3 : Estimated Cancer Incidence Cases, by Region, 2022–2045
Table 4 : Estimated Cancer Incidence Cases in Males in the U.S., by Cancer Site, 2025
Table 5 : Estimated Cancer Incidence Cases in Females in the U.S., by Cancer Site, 2025
Table 6 : Regulatory Landscape Governing Organoids and Spheroids Solutions, by Country or Region
Table 7 : Number of Patents, by Jurisdiction, 2024–2025
Table 8 : Global Market for Organoids and Spheroids, by Product Type, Through 2031
Table 9 : Global Market for Organoids, by Region, Through 2031
Table 10 : Global Market for Spheroids, by Region, Through 2031
Table 11 : Global Market for Organoids and Spheroids, by Application, Through 2031
Table 12 : Global Market for Organoids and Spheroids for Drug Discovery and Personalized Medicine, by Region, Through 2031
Table 13 : Global Market for Organoids and Spheroids for Developmental Biology, by Region, Through 2031
Table 14 : Global Market for Organoids and Spheroids for Disease Pathology Studies, by Region, Through 2031
Table 15 : Global Market for Organoids and Spheroids for Drug Toxicity and Efficacy Testing, by Region, Through 2031
Table 16 : Global Market for Organoids and Spheroids for Regenerative Medicine, by Region, Through 2031
Table 17 : Global Market for Organoids and Spheroids, by End User, Through 2031
Table 18 : Global Market for Organoids and Spheroids for Pharmaceutical and Biotechnology Companies, by Region, Through 2031
Table 19 : Global Market for Organoids and Spheroids for Academic and Research Institutes, by Region, Through 2031
Table 20 : Global Market for Organoids and Spheroids for Contract Research Organizations, by Region, Through 2031
Table 21 : Global Market for Organoids and Spheroids for Hospitals and Diagnostic Centers, by Region, Through 2031
Table 22 : Global Market for Organoids and Spheroids for Other End Users, by Region, Through 2031
Table 23 : Global Market for Organoids and Spheroids, by Region, Through 2031
Table 24 : North American Market for Organoids and Spheroids, by Country, Through 2031
Table 25 : North American Market for Organoids and Spheroids, by Product Type, Through 2031
Table 26 : North American Market for Organoids and Spheroids, by Application, Through 2031
Table 27 : North American Market for Organoids and Spheroids, by End User, Through 2031
Table 28 : European Market for Organoids and Spheroids, by Country, Through 2031
Table 29 : European Market for Organoids and Spheroids, by Product Type, Through 2031
Table 30 : European Market for Organoids and Spheroids, by Application, Through 2031
Table 31 : European Market for Organoids and Spheroids, by End User, Through 2031
Table 32 : Asia-Pacific Market for Organoids and Spheroids, by Country, Through 2031
Table 33 : Asia-Pacific Market for Organoids and Spheroids, by Product Type, Through 2031
Table 34 : Asia-Pacific Market for Organoids and Spheroids, by Application, Through 2031
Table 35 : Asia-Pacific Market for Organoids and Spheroids, by End User, Through 2031
Table 36 : South American Market for Organoids and Spheroids, by Country, Through 2031
Table 37 : South American Market for Organoids and Spheroids, by Product Type, Through 2031
Table 38 : South American Market for Organoids and Spheroids, by Application, Through 2031
Table 39 : South American Market for Organoids and Spheroids, by End User, Through 2031
Table 40 : MEA Market for Organoids and Spheroids, by Subregion, Through 2031
Table 41 : MEA Market for Organoids and Spheroids, by Product Type, Through 2031
Table 42 : MEA Market for Organoids and Spheroids, by Application, Through 2031
Table 43 : MEA Market for Organoids and Spheroids, by End User, Through 2031
Table 44 : Leading Providers of Organoids and Spheroids, 2025
Table 45 : Recent Developments in the Organoids and Spheroids Market, January 2024 to June 2026
Table 46 : Abbreviations Used in This Report
Table 47 : Bio-Techne: Company Snapshot
Table 48 : Bio-Techne: Financial Performance, FY 2023 and 2024
Table 49 : Bio-Techne: Product Portfolio
Table 50 : Corning Inc.: Company Snapshot
Table 51 : Corning Inc.: Financial Performance, FY 2024 and 2025
Table 52 : Corning Inc.: Product Portfolio
Table 53 : Corning Inc.: News/Key Developments, 2025
Table 54 : Greiner Bio-One International GmbH: Company Snapshot
Table 55 : Greiner Bio-One International GmbH: Product Portfolio
Table 56 : InSphero: Company Snapshot
Table 57 : InSphero: Product Portfolio
Table 58 : InSphero: News/Key Developments, 2024–2026
Table 59 : Lonza: Company Snapshot
Table 60 : Lonza: Financial Performance, FY 2024 and 2025
Table 61 : Lonza: Product Portfolio
Table 62 : Merck KGaA: Company Snapshot
Table 63 : Merck KGaA: Financial Performance, FY 2024 and 2025
Table 64 : Merck KGaA: Product Portfolio
Table 65 : Merck KGaA: News/Key Developments, 2025
Table 66 : Molecular Devices LLC.: Company Snapshot
Table 67 : Molecular Devices LLC.: Product Portfolio
Table 68 : Revvity: Company Snapshot
Table 69 : Revvity: Financial Performance, FY 2024 and 2025
Table 70 : Revvity: Product Portfolio
Table 71 : STEMCELL Technologies: Company Snapshot
Table 72 : STEMCELL Technologies: Product Portfolio
Table 73 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 74 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2024 and 2025
Table 75 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 76 : List of a Few Emerging Startups/Market Disruptors

List of Figures
Summary Figure : Global Market Shares for Organoids and Spheroids, by Region, 2025
Figure 1 : Porter's Five Forces Analysis: Organoids and Spheroids Market
Figure 2 : Market Dynamics of Organoids and Spheroids
Figure 3 : Emerging Technologies in the Organoids and Spheroids Market
Figure 4 : Total Number of Patents, by Year, 2024 and 2025
Figure 5 : Global Market Shares for Organoids and Spheroids, by Product Type, 2025
Figure 6 : Global Market Shares for Organoids, by Region, 2025
Figure 7 : Global Market Shares for Organoids, by Type, 2025
Figure 8 : Global Market Shares for Spheroids, by Region, 2025
Figure 9 : Global Market Shares for Spheroids, by Type, 2025
Figure 10 : Global Market Shares for Organoids and Spheroids, by Application, 2025
Figure 11 : Global Market Shares for Organoids and Spheroids for Drug Discovery and Personalized Medicine, by Region, 2025
Figure 12 : Global Market Shares for Organoids and Spheroids for Developmental Biology, by Region, 2025
Figure 13 : Global Market Shares for Organoids and Spheroids for Disease Pathology Studies, by Region, 2025
Figure 14 : Global Market Shares for Organoids and Spheroids for Drug Toxicity and Efficacy Testing, by Region, 2025
Figure 15 : Global Market Shares for Organoids and Spheroids for Regenerative Medicine, by Region, 2025
Figure 16 : Global Market Shares for Organoids and Spheroids, by End User, 2025
Figure 17 : Global Market Shares for Organoids and Spheroids for Pharmaceutical and Biotechnology Companies, by Region, 2025
Figure 18 : Global Market Shares for Organoids and Spheroids for Academic and Research Institutes, by Region, 2025
Figure 19 : Global Market Shares for Organoids and Spheroids for Contract Research Organizations, by Region, 2025
Figure 20 : Global Market Shares for Organoids and Spheroids for Hospitals and Diagnostic Centers, by Region, 2025
Figure 21 : Global Market Shares for Organoids and Spheroids for Other End Users, by Region, 2025
Figure 22 : Global Market Shares for Organoids and Spheroids, by Region, 2025
Figure 23 : North American Market Shares for Organoids and Spheroids, by Country, 2025
Figure 24 : European Market Shares for Organoids and Spheroids, by Country, 2025
Figure 25 : Asia-Pacific Market Shares for Organoids and Spheroids, by Country, 2025
Figure 26 : South American Market Shares for Organoids and Spheroids, by Country, 2025
Figure 27 : MEA Market Shares for Organoids and Spheroids, by Subregion, 2025
Figure 28 : Bio-Techne: Revenue Share, by Business Unit, FY 2024
Figure 29 : Bio-Techne: Revenue Share, by Country/Region, FY 2024
Figure 30 : Corning Inc.: Revenue Shares, by Business Unit, FY 2025
Figure 31 : Corning Inc.: Revenue Shares, by Country/Region, FY 2025
Figure 32 : Lonza: Revenue Shares, by Business Unit, FY 2025
Figure 33 : Lonza: Revenue Shares, by Country/Region, FY 2025
Figure 34 : Merck KGaA: Revenue Share, by Business Unit, FY 2025
Figure 35 : Merck KGaA: Revenue Share, by Country/Region, FY 2025
Figure 36 : Revvity: Revenue Shares, by Business Unit, FY 2025
Figure 37 : Revvity: Revenue Shares, by Country/Region, FY 2025
Figure 38 : Thermo Fisher Scientific Inc.: Revenue Shares, by Business Unit, FY 2025
Figure 39 : Thermo Fisher Scientific Inc.: Revenue Shares, by Country/Region, FY 2025